Genomic Health (GHDX) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $85.5 million versus the consensus estimate of $86.08 million.
GUIDANCE:
Genomic Health sees FY2017 revenue of $345-355 million, versus the consensus of $356.1 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
